Compounded Semaglutide
We understand weight loss isn’t about willpower— it’s about consistency. Lose up to 14.9% of your body weight with this simple, weekly GLP-1— tailored just to you.
$99 for your first month (Normal price $297)
$196 first month | $296/mo after
What is compounded semaglutide?
Compounded semaglutide (compounded GLP-1) can be a medication prescribed for weight loss. It contains the same active ingredient as the groundbreaking medications Wegovy® and Ozempic®.
Compounded GLP-I medications work by mimicking hormones that regulate appetite and digestion — potentially leading to weight loss when combined with diet and exercise.
Compounded semaglutide is customized uniquely for each individual by a state licensed compounding pharmacy. Once prescribed by one of Goals’s network of licensed healthcare professionals, compounded semaglutide is self-injected just once a week.
Is compounded semaglutide safe?
At Goal, we source compounded semaglutide from accredited 503a compounding pharmacies that have a reputation for safety. However, like any medication, there may be side effects. These are usually mild and go away within a couple of weeks. See more safety information here.
Why choose Goal MD for compounded semaglutide?
Goal’s personalized weight loss solutions are focused on you. Access to injectable (compounded) semaglutide is sourced from audited and licensed US-based compounding pharmacies. It is always available in a customized dosage catered to your specific needs. We also offer a free initial consultation with a network healthcare provider, consistent pricing regardless of dose, and 24/7 access to online support.
We understand weight loss isn’t about willpower— it’s about consistency. Lose up to 14.9% of your body weight with this simple, weekly GLP-1— tailored just to you.
Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or address drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness. Compounded semaglutide has not been approved by the FDA for weight loss, but studies indicate potential benefits. Results may vary.
*After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight. The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. (Source)
Safely and affordably hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medication
Reduces the need for restrictive diets by naturally regulating appetite, offering a sustainable way to manage weight long-term.
*When combined with diet and exercise.
Associated with improved heart health, lower cholesterol levels, and enhanced overall metabolic health.
*Source: PubMed Central and National Library of Medicine
Has been found to improve blood sugar levels, which may reduce the risk of type 2 diabetes.
*Source: National Library of Medicine
Renewed willpower - centered on biology.
Our approach to sustainable weight loss rejects conventional diets and calorie counting. Goal.MD focuses on improving metabolic health, paving the way for lasting results.
Experience an average
weight loss of
while on a GLP-1 medication like Semaglutide*
Health gains beyond numbers
Semaglutide has been shown to improve blood sugar control and diabetes risk. GLP-1 medications have also been found to help protect the heart, lowering the risk of cardiovascular complications, like stroke and heart attack, by up to 14 percent in those with obesity and diabetes.*
*A study found GLP-1 RAs to be associated with a significant 12-14% reduction in major adverse cardiovascular events (Source)
Goal members report
an average of
lost in the first month**
*After 68 weeks, participants administering once-weekly semaglutide treatment (combined with diet and exercise) experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
**Weight loss based on self reported data from 160 Goal members while on GLP-1 injections, while combined with diet and exercise.
How does it work?
Lose Weight Faster, Accelerated Program
NEW - Now up to 250% More Powerful
Flat Monthly Fee* Regardless of Dose
Doctors & Medication Included
Shipped Overnight to Your Home
Take a 3-min quiz to see if you qualify
Tirzepatide & Semaglutide
No hidden fees. No separate membership. It’s that simple.
Join the Goal.MD Community today. To get started, after billing you will receive everything you need. Every 4 weeks, when your medication refills, you will be billed again.
Proven results,
clinically tested
Semaglutide has been shown to improve blood sugar control and diabetes risk. GLP-1 medications have also been found to help protect the heart, lowering the risk of cardiovascular complications, like stroke and heart attack, by up to 14 percent in those with obesity and diabetes.*
Our pharmacies perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Goal patients. They test four key characteristics that are associated with quality and safety.
Member success stories
Showing our 3, 4 & 5 star reviews
Same Price at Every Dose
Our promise is simple: the price you see for any medication is the price you’ll pay, regardless of dosage. Every time. We’re committed to making metabolic health affordable for all, ensuring that the first and last month’s prices will never change, no matter what.
100% Money-Back Guarantee
If at any point during the onboarding process you are found ineligible for semaglutide medication prescription, Goal.MD will provide a full refund of 100% of your initial payment.
Supercharge your weight loss goals
* Cardiovascular Disease Risk Factors: Improvement in triglycerides and systolic blood pressure begins with 2-5% weight loss. For diastolic blood pressure and HDL cholesterol, improvement begins at 5-10% weight loss. (Source)
Emotional Health: Pursuing dietary interventions for obese patients with comorbid depression could have the additional benefit of relieving some of their depressive symptoms as well as improving their metabolic profile and cardiovascular risk. (Source)
Weight Loss: After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo. (Source)
